- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03148600
Rehabilitation After Ileo-anal Pouch Surgery (RAP)
April 11, 2023 updated by: Angela Khera, St Vincent's Hospital Melbourne
Behavioural Treatment Following Ileo-Anal Pouch Formation:
Multi-centre, assessor-blinded, randomised controlled trial comparing physiotherapist-led behavioural intervention (including pelvic floor muscle training) to standard care, in the management of post-operative ileo-anal pouch patients.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Victoria
-
Fitzroy, Victoria, Australia, 3065
- Recruiting
- St Vincent's Hospital
-
Prahran, Victoria, Australia, 3181
- Not yet recruiting
- Alfred Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Proven (documented) history of Ulcerative Colitis or Familial Adenomatous Polyposis
- Proctocolectomy and awaiting ileo-anal pouch formation or have had ileo-anal pouch created and are waiting for stoma reversal or have had stoma reversal within the last 60 days
Exclusion Criteria:
- Primary sclerosing cholangitis
- Significant medical or psychiatric comorbidity that in the opinion of the investigators would interfere with bowel function or adherence to the protocol
- Clinically significant narcotic or substance abuse that in the opinion of the investigators would interfere with bowel function or adherence to the protocol
- Recognised eating disorder
- Non- English speaking or illiterate
- Pregnancy
- Current participant in another trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Intervention arm
Pelvic floor and bowel behavioural training programme provided by physiotherapists over 2- 6 sessions within the 6 months following ileostomy closure for patients with an ileo-anal pouch
|
Physiotherapist-led pelvic floor muscle and bowel behavioural training
|
Placebo Comparator: Standard arm
Standard post-operative nursing and medical care provided in hospital clinic
|
Standard medical and nursing care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Colo Rectal Functional Outcome Score (COREFO)
Time Frame: 6 and 12 months following ileostomy reversal
|
Between group comparison of outcome score - total and each of 5 domains
|
6 and 12 months following ileostomy reversal
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pouch Dysfunction score
Time Frame: 1,3,6 and 12 months following ileostomy closure
|
Comparison of scores between groups
|
1,3,6 and 12 months following ileostomy closure
|
Quality of Life Short-Form 36 (SF-36)
Time Frame: Baseline, 3,6 and 12 months following ileostomy closure
|
Quality of life SF-36 compared between groups - mental health domain, physical health domain and total score
|
Baseline, 3,6 and 12 months following ileostomy closure
|
Quality of Life EQ-5D
Time Frame: Baseline,3,6 and 12 months following ileostomy closure
|
Scores from the EQ-5D will be compared between groups and quality adjusted life years (QALY) will be derived from EQ-5D.
|
Baseline,3,6 and 12 months following ileostomy closure
|
Inflammatory Bowel Disease Questionnaire (IBDQ)
Time Frame: Baseline,3,6 and 12 months following ileostomy closure
|
Disease specific quality of life score comparing groups
|
Baseline,3,6 and 12 months following ileostomy closure
|
Hospital Anxiety and Depression Scale (HADs)
Time Frame: Baseline,3,6 and 12 months following ileostomy closure
|
Psychological well being scores for anxiety and depression comparing groups
|
Baseline,3,6 and 12 months following ileostomy closure
|
Brief Illness Perception Questionnaire
Time Frame: Baseline,3,6 and 12 months following ileostomy closure
|
Between group comparison of cognitive and emotional perceptions of illness
|
Baseline,3,6 and 12 months following ileostomy closure
|
Brief Cope
Time Frame: Baseline,3,6 and 12 months following ileostomy closure
|
Between group comparison of coping styles and ability to cope with stress
|
Baseline,3,6 and 12 months following ileostomy closure
|
New General Self-Efficacy Scale
Time Frame: Baseline,3,6 and 12 months following ileostomy closure
|
Between group comparison of confidence in ability to perform tasks and achieve goals
|
Baseline,3,6 and 12 months following ileostomy closure
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Global Impression of Improvement and Satisfaction
Time Frame: 3,6 and 12 months following ileostomy closure
|
Between group comparison of patient rating of improvement and satisfaction on 7-point Likert Scales
|
3,6 and 12 months following ileostomy closure
|
Adherence
Time Frame: 1,2,3,4,5 and 6 months following ileostomy closure
|
Patient rating of their level of adherence to the training programme
|
1,2,3,4,5 and 6 months following ileostomy closure
|
Pelvic floor muscle function
Time Frame: Baseline and 6 months following ileostomy closure
|
Transperineal measurements of displacement of puborectalis and change in anorectal angle with pelvic floor muscle contraction and with simulated defaecation
|
Baseline and 6 months following ileostomy closure
|
Cost to the healthcare system
Time Frame: Baseline, 6 and 12 months following ileostomy closure
|
Compare health care utilisation between groups
|
Baseline, 6 and 12 months following ileostomy closure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 20, 2017
Primary Completion (Anticipated)
June 30, 2024
Study Completion (Anticipated)
December 31, 2024
Study Registration Dates
First Submitted
April 20, 2017
First Submitted That Met QC Criteria
May 8, 2017
First Posted (Actual)
May 11, 2017
Study Record Updates
Last Update Posted (Actual)
April 12, 2023
Last Update Submitted That Met QC Criteria
April 11, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- HREC/16/SVHM/214
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Therapy Modalities
-
Cairo UniversityCompleted
-
Children's Hospitals and Clinics of MinnesotaRecruitingNeoplasms | Survivorship | Physical Therapy ModalitiesUnited States
-
University of California, DavisCompletedPediatrics | Physical Therapy Modalities | Physical and Rehabilitation MedicineUnited States
-
Beni-Suef UniversityAzhar UniversityEnrolling by invitationPhysical Disability | Physical Therapy ModalitiesEgypt
-
University of VigoRecruitingExercise Therapy | Physical Therapy Modalities | Hamstring MusclesSpain
-
University of NebraskaRecruitingPediatric ALL | Child, Hospitalized | Occupational Therapy | Physical Therapy Modalities | Animal Assisted TherapyUnited States
-
University of NebraskaCompletedCritical Illness | Pediatric ALL | Occupational Therapy | Physical Therapy Modalities | Animal Assisted TherapyUnited States
-
Universidade Federal de PernambucoUnknownObesity | Bariatric Surgery | Physical Therapy ModalitiesBrazil
-
University of Maryland, BaltimoreNational Institute on Aging (NIA); US Department of Veterans AffairsCompletedCritical Illness | Chronic Disease | Rehabilitation | Respiration, Artificial | Exercise Therapy | Physical Therapy ModalitiesUnited States
-
Universidad de LeónCompletedObstetric Labor Complications | Primary Prevention | Musculoskeletal Manipulations | Physical Therapy ModalitiesSpain
Clinical Trials on Pelvic floor and bowel behavioural training
-
Trakya UniversityCompletedStress Urinary Incontinence | Pelvic Floor Muscle Weakness
-
Herlev HospitalCompletedUrinary Stress IncontinenceDenmark
-
Hatice Gulsah KurneRecruitingSexual Dysfunction | Pelvic Floor Muscle Weakness | Postmenopausal SymptomsTurkey
-
Hacettepe UniversityCompletedStress Urinary IncontinenceTurkey
-
Centre Hospitalier Universitaire de la RéunionInstitut National de la Santé Et de la Recherche Médicale, France; CIC-EC RéunionCompletedUrinary Incontinence | Anal Incontinence | Genital ProlapseFrance
-
Norwegian School of Sport SciencesTerminatedUrinary Incontinence | Stress Urinary IncontinenceNorway
-
University of the Balearic IslandsFundació d'investigació Sanitària de les Illes Balears; Consejo Superior de...CompletedPelvic Floor DisordersSpain
-
Hasan Kalyoncu UniversityNot yet recruiting
-
Hospital de Clinicas de Porto AlegreWithdrawn
-
Dokuz Eylul UniversityIzmir Katip Celebi UniversityCompletedMultiple Sclerosis | Urinary IncontinenceTurkey